Roivant Sciences-Does Montes Archimedes Acquisition (ROIV) Have the Potential to Rally 35.12% as Wall Street Analysts Expect?

Roivant Sciences Ltd. (ROIV) closed the last trading session at $12.50, gaining 11.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 16.89 indicates a 35.1% upside potential. The mean estimate comprises nine short-term price targets with a standard deviation of $2.62. While the lowest estimate of$ 12 indicates a 4% decline from the current price level, the most optimistic analyst ...